• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表现为局灶性神经功能缺损的甲状腺乳头状癌复发

Recurrence of papillary thyroid carcinoma presenting as a focal neurologic deficit.

作者信息

Parker L N, Wu S Y, Kim D D, Kollin J, Prasasvinichai S

出版信息

Arch Intern Med. 1986 Oct;146(10):1985-7.

PMID:3767543
Abstract

Papillary-follicular thyroid carcinoma usually remains localized to the thyroid bed and, in cases of metastasis, almost always involves the lung, bone, or liver. The two patients described here presented with papillary carcinoma and neurologic dysfunction. Total body iodine 131 scans disclosed cerebral uptake, and cerebral masses were confirmed by computed tomographic scan. Both patients presented diagnostic and therapeutic dilemmas, and ultimately underwent craniotomy. One patient's cerebral metastasis recurred and was treated by a second craniotomy. The other patient received postoperative external cerebral radiotherapy and a novel intraoperative treatment: implantation of 22 iodine 125 seeds in the tumor bed, estimated to yield 16,000 rad (160 Gy) in one year. To date, cerebral metastases have not recurred in the latter patient, although tumor has reappeared in other sites. There is little reported in the medical literature concerning cerebral metastases of thyroid carcinoma, and the present report reviews this experience and discusses treatment alternatives.

摘要

乳头状滤泡状甲状腺癌通常局限于甲状腺床,发生转移时,几乎总是累及肺、骨或肝。这里描述的两名患者表现为乳头状癌和神经功能障碍。全身碘131扫描显示脑部有摄取,脑部肿块经计算机断层扫描得以证实。两名患者均面临诊断和治疗难题,最终都接受了开颅手术。其中一名患者的脑转移复发,再次接受了开颅手术。另一名患者术后接受了脑部外照射放疗以及一种新型术中治疗:在瘤床植入22颗碘125粒子,估计一年可产生16000拉德(160戈瑞)的剂量。迄今为止,后一名患者的脑转移未复发,不过其他部位出现了肿瘤复发。医学文献中关于甲状腺癌脑转移的报道很少,本报告回顾了这一经验并讨论了治疗方案。

相似文献

1
Recurrence of papillary thyroid carcinoma presenting as a focal neurologic deficit.表现为局灶性神经功能缺损的甲状腺乳头状癌复发
Arch Intern Med. 1986 Oct;146(10):1985-7.
2
Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.首次放射性碘治疗后复发的甲状腺乳头状癌患者的临床结局
Cancer. 1996 Aug 1;78(3):493-501. doi: 10.1002/(SICI)1097-0142(19960801)78:3<493::AID-CNCR17>3.0.CO;2-U.
3
Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.儿童和青少年分化型甲状腺癌:85例患者的37年经验
J Nucl Med. 1997 May;38(5):669-75.
4
[Solitary brain metastasis of thyroid papillary carcinoma mimicking a cavernous angioma by MRI].[甲状腺乳头状癌的孤立性脑转移瘤在MRI上酷似海绵状血管瘤]
No Shinkei Geka. 2009 May;37(5):467-72.
5
[Brain metastases from papillary thyroid carcinoma: a case report and review of the literature].[甲状腺乳头状癌脑转移:1例病例报告并文献复习]
Rev Hosp Clin Fac Med Sao Paulo. 1997 Sep-Oct;52(5):263-6.
6
Sudden hemorrhage in metastatic thyroid carcinoma of the brain during treatment with iodine-131.碘-131治疗期间脑转移性甲状腺癌突发出血。
J Nucl Med. 1976 Apr;17(4):307-9.
7
Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.放射性碘治疗及外照射放疗用于甲状腺癌肺和骨转移
J Nucl Med. 1996 Apr;37(4):598-605.
8
[Prospective therapy study in differentiated thyroid carcinoma].[分化型甲状腺癌的前瞻性治疗研究]
Schweiz Med Wochenschr. 1995 Nov 18;125(46):2226-36.
9
Acute toxicity of adjuvant radiotherapy in locally advanced differentiated thyroid carcinoma. First results of the multicenter study differentiated thyroid carcinoma (MSDS).局部晚期分化型甲状腺癌辅助放疗的急性毒性。多中心分化型甲状腺癌研究(MSDS)的初步结果。
Strahlenther Onkol. 2003 Dec;179(12):832-9. doi: 10.1007/s00066-003-1158-1.
10
[Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].[IV期非小细胞肺癌患者放疗后的生存状况——附287例报告]
Ai Zheng. 2006 Nov;25(11):1419-22.

引用本文的文献

1
Prognostic factors to predict the efficacy of surgical interventions against brain metastasis secondary to thyroid cancer.预测手术干预对甲状腺癌继发脑转移疗效的预后因素。
Eur Thyroid J. 2022 Aug 1;11(5). doi: 10.1530/ETJ-22-0087. Print 2022 Oct 1.
2
I Seed Brachytherapy for Refractory Loco-Regional Recurrence of Non-Anaplastic Thyroid Cancer.I 粒子近距离放射治疗非间变性甲状腺癌难治性局部区域复发
Front Oncol. 2022 Feb 15;12:773708. doi: 10.3389/fonc.2022.773708. eCollection 2022.
3
3D-Printed Template-Guided I Seed Brachytherapy: A Salvage Approach for Locoregional Refractory Recurrence of Papillary Thyroid Cancer.
3D打印模板引导下碘-125粒子近距离放射治疗:甲状腺乳头状癌局部区域难治性复发的挽救性治疗方法
Eur Thyroid J. 2021 Nov;10(6):504-510. doi: 10.1159/000519572. Epub 2021 Oct 4.
4
Unusual Sites of Metastatic and Benign I 131 Uptake in Patients with Differentiated Thyroid Carcinoma.分化型甲状腺癌患者中I 131摄取的转移和良性异常部位
Indian J Endocrinol Metab. 2018 Nov-Dec;22(6):740-750. doi: 10.4103/ijem.IJEM_70_18.
5
Brain Metastases From Differentiated Thyroid Carcinoma: Prevalence, Current Therapies, and Outcomes.分化型甲状腺癌脑转移:患病率、当前治疗方法及治疗结果
J Endocr Soc. 2018 Nov 21;3(2):359-371. doi: 10.1210/js.2018-00241. eCollection 2019 Feb 1.
6
Metastatic cerebellar tumor of papillary thyroid carcinoma mimicking cerebellar hemangioblastoma.模仿小脑成血管细胞瘤的甲状腺乳头状癌转移性小脑肿瘤。
Springerplus. 2016 Jun 29;5(1):916. doi: 10.1186/s40064-016-2551-4. eCollection 2016.
7
When Evaluating a New Thyroid Mass and a Ring-Enhancing Brain Lesion (When Two Presentations Collide).评估新发甲状腺肿块与环形强化脑病变(两种表现同时出现时)
Cureus. 2016 May 4;8(5):e600. doi: 10.7759/cureus.600.
8
Image-guided high-dose-rate interstitial brachytherapy - a valuable salvage treatment approach for loco-regional recurrence of papillary thyroid cancer.图像引导下的高剂量率组织间近距离放射治疗——一种用于乳头状甲状腺癌局部区域复发的有价值的挽救性治疗方法。
J Contemp Brachytherapy. 2016 Apr;8(2):150-5. doi: 10.5114/jcb.2016.59127. Epub 2016 Apr 7.
9
Long-term survival in a patient with brain metastases of papillary thyroid carcinoma.一名甲状腺乳头状癌脑转移患者的长期生存情况。
BMJ Case Rep. 2016 Mar 9;2016:bcr2015213824. doi: 10.1136/bcr-2015-213824.
10
Cerebral metastases from thyroid carcinoma: complete remission following radioiodine treatment.甲状腺癌脑转移:放射性碘治疗后完全缓解
Dtsch Arztebl Int. 2013 Dec 13;110(50):861-6. doi: 10.3238/arztebl.2013.0861.